Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology.

In each episode, we’ll bring you daily news and analysis from the world of medical devices, exploring the cutting-edge products and treatments that are revolutionizing healthcare. From innovative diagnostic tools to life-saving implants and beyond, we’ll take a deep dive into the business, science and engineering news that powers these remarkable innovations.

Subscribe to the MassDevice Fast Five and join us every weekday for your daily medtech roundup. Thank you for listening.

Trailer: Welcome to the MassDevice medtech news podcast

In episode 3 of Transformational Healthcare Leadership, Dr Mark O’Brien hands the microphone over to his colleague Eleanor Murray, Academic Director of the Oxford Healthcare Leadership Programme. The setting for this episode is India where Eleanor explores the innovative approach to healthcare in the world’s most populous country, with Professor Anupam Sibal.

‘It doesn't always take huge amounts of money to be able to innovate. And I think India has many examples of frugal innovation.’

Professor Anupam Sibal is the Group Director of Medical Services for Apollo Healthcare India, an integrated healthcare delivery system with a strong physical and digital presence spanning the healthcare spectrum and covering all levels of patient care. 

For centuries innovation has been at the heart of the incredible advances we have seen in medical diagnostics, treatments and cures. But for Anupam what sets India apart from other countries is not just its spirit of innovation but its spirit of ‘frugal innovation’ – always asking how you can get more from that one pound or one dollar. Medical equipment is expensive he explains so you need to ‘sweat those assets’ for maximum return.

Investment in healthcare is a long-term strategy for Apollo Healthcare and that means investment in education which is the bedrock of future patient care. But their investment goes beyond the bricks and mortar of their schools and colleges with a strategy to leverage technology for upskilling.

And with a workforce of 750 million India will not only be able to cater for the healthcare needs of India but will also be able to help heal the ageing global population.

Featuring: 

Mark O’Brien, Programme Director of the Oxford Healthcare Leadership Programme - www.sbs.ox.ac.uk/about-us/people/mark-obrien
Eleanor Murray, Academic Director of the Oxford Healthcare Leadership Programme - https://www.sbs.ox.ac.uk/about-us/people/eleanor-murray
Anupam Sibal, Group Director of Medical Services for Apollo Healthcare India - https://in.linkedin.com/in/prof-anupam-sibal-bb1b1954?original_referer=https%3A%2F%2Fwww.google.com%2F

• Learn more about the Oxford Healthcare Leadership Programme - https://www.sbs.ox.ac.uk/programmes/executive-education/campus-open-programmes/oxford-healthcare-leadership-programme
• Explore Oxford Answers for more insights from Saïd Business School on the challenges and opportunities leaders of the future need to consider in an age of digital, social and environmental disruption - www.sbs.ox.ac.uk/oxford-answers 
• Follow us on Twitter @OxfordSBS and on LinkedIn at www.linkedin.com/school/4476/admin/

Credits: 
Transformational Healthcare Leadership is produced by Chris Ashmore Media - www.chrisashmore.media

Transformational Healthcare Leadership: Anupam Sibal

Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, Dec. 7, 2023.

Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.

Merit Medical upsized a private placement to $650 million and could bring in as much as $725 million from the offering. Fast Five hosts Jim Hammerand and Sean Whooley look at the details of the offering, as well as Merit's potential plans with the proceeds.

The hosts look at a major reimbursement win for Ambu, breaking down some of the features of the company's single-use bronchoscope technology and why CMS decided to allow incremental reimbursement for outpatient procedures.

Levita Magnetics announced the completion of the first procedures outside the U.S. with its surgical robotic technology. Hear all about the magnetic-based MARS platform, the surgeries that took place in South America and what this milestone means to Levita's CEO.

Medtronic earned CE mark for the latest device in its Precept family of deep brain stimulation implants. While it remains investigational in the U.S., the hosts look at what this implant brings to the European market as a first-of-its-kind offering.

In a milestone announcement for diabetes technology, Tandem Diabetes Care and Dexcom say they launched an integrated artificial pancreas system using Tandem's pump technology and Dexcom's next-generation G7 CGM. Whooley and Hammerand explain the significance of this integration and the benefits for users of the technology.

Tandem integrates Dexcom G7 into insulin pumps, Medtronic wins CE mark for neurostim tech

In this episode of AbbottTalks, Sandra Lesenfants, SVP of Abbott’s structural heart business, discusses the latest advancements in structural heart care, focusing on Abbott's transformative TriClip device for tricuspid regurgitation.

Lesenfants highlights Abbott’s commitment to patient-centered innovation, emphasizing the importance of creating solutions that meet patients’ needs through safe and effective technologies. She also shares Abbott’s approach to expanding access to minimally invasive therapies, particularly in underserved populations worldwide, and the role of physician partnerships in advancing structural heart interventions.

Lastly, Lesenfants underscores the company’s efforts to increase diversity in clinical trials, noting the importance of intentional inclusivity across gender and ethnicity to better serve diverse patient populations.

Thank you to Confluent Medical Technologies for sponsoring this episode of AbbottTalks. For more information on how Confluent Medical works with medical device companies, visit https://confluentmedical.com/.

Thank you for listening to the AbbottTalks Podcast. Tune in and subscribe to DeviceTalks on all major podcast channels to never miss an episode.

Abbott’s Lesenfants shares TriClip progress, patient-centered innovation & clinical trial diversity

In this episode of DeviceTalks Weekly, Tom Salemi and Chris Newmarker tackle some of the weeks’ biggest news including the FDA giving a nod to Distalmotion’s Dexter robot and the Yankees blowing the World Series. 

Distalmotion CEO Greg Roche visits to share his thoughts on both. Then Tom interviews Chad Hoskins, CEO of Phagenesis, a startup developing a neurostimulation device that could help stroke survivors recover.

This week’s Newmaker’s Newsmakers include Medtronic, Masimo, Exactech, Solventum and you already know about this week’s number one.

This episode is sponsored by DeviceTalks Boston. Register now at Boston.DeviceTalks.com.

Thanks for listening to this episode of the DeviceTalks Weekly Podcast.

Subscribe now to the DeviceTalks Podcast Network so you don’t miss a future episode.

Phagenesis CEO Hoskins on helping stroke survivors recover; How Distalmotion will target ASCs

In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi interviews Marwan Berrada, founder and managing partner of Santa Clara-based T45 Labs about how incubators can start new companies at a time when early-stage funding is scarce.

MassDevice Editor Chris Newmarker deliveres his Newmarker’s Newsmakers including GE HealthCare, Zimmer Biomet, Momentis Surgical, Johnson & Johnson MedTech and, of course, the news surrounding HHS.

This episode is sponsored by DeviceTalks Boston. Register at Boston.DeviceTalks.com.

Thanks for listening to the DeviceTalks Weekly Podcast.

Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

Can T45 Labs use its cross-country connections to bypass MedTech’s early-stage funding shortage?

In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi interviews Todd Langevin, president of BIOTRONIK Neuro, a familiar name in medical devices with a new approach to alleviating pain through spinal cord stimulation. Langevin, who has spent his career in neuro devices, gives his assessment of the field today, explaining how it’s exceeded his early expectations.

Just before that Tom talks with Joe Mullings of The Mullings Group and Surgical Robotics Expert Steve Bell about the state of the surgical robotics industry. The trio will talk about current leaders, emerging powers, and how a shift toward cardiac surgeons could change the playing field completely.

But to start, MassDevice Editor Chris Newmarker joins Tom for the Newmarker’s Newsmakers, the leading stories from the pages of MassDevice. This week’s newsmakers include Tariffs, Medtronic, Surgical Robotics, Stryker, and BCI company Paradromics.

Thank you for listening to this episode of the DeviceTalks Weekly Podcast.

Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

BIOTRONIK Neuro’s Langevin talks power of connected spinal stim; What’s Next in Surgical Robotics

In this special In Vivo podcast episode, executive editor Lucie Ellis-Taitt is joined by an expert panel of Citeline journalists – Ashley Yeo, David Wild, Jessica Merrill and data journalist Edwin Elmhirst – to explore the trends set to reshape the biopharma and medtech sectors as we head into 2026.

Data-Driven Insights Reveal The Growth Engines Powering 2026 Life Sciences

This is Compliance 360°, an eight-part podcast series from Medtech Insight on US FDA compliance and enforcement issues. In this sixth installment, former FDA investigations branch director Ricki Chase explains how your firm can best respond to the agency following the issuance of an FDA-483 inspection form.

Compliance 360

Compliance 360° Part 6: Don’t Do That! How To Respond To FDA-483s

Most of us have read about, observed, participated in, and spoke with healthcare providers and medical device professionals collaborating during the COVID-19 crisis. 

Creativity within reason can be an opportunity. Like many things in life, it’s not what happens to us that counts, it’s how we choose to respond. COVID-19 is not an excuse to cut corners.

In this episode of the Global Medical Device Podcast Jon Speer invites guest Mike Drues of Vascular Sciences to join the show. Together, they share their own COVID-19 observations and insights into what has gone right and wrong, so far, for the medical device industry.

Some of the highlights of the show include:
•  COVID-19’s unintended consequences on the medical device industry include new and agile product development, but funding challenges for some startups.
•  Emergency Use Authorization (EUA) is temporary, until the Secretary of Health and Human Services declares that the period of emergency is over.
•  Why is funding and regulatory pathways easier for COVID-19 medical devices? Devices already on the market can be modified or changed for a COVID indication. However, the ability to manage investors’ expectations is important.
•  Quick turnaround or years to go till getting back to business as usual? There’s always a need for short- and long-term opportunities to market medical devices.
•  Clinical Trials and Investigations: Healthcare providers and hospitals are shifting and reallocating resources to address perceived demand related to COVID crisis.
•  EUA equates to 510(k) due to underlying assumption of safety and efficacy, but EUA is not substantially equivalent to De Novo or PMA.
•  Altruistic vs. Opportunistic Attitudes: Filter motives, products, and people to accomplish post-market surveillance obligations, especially for COVID devices.
•  Lessons Learned: React accordingly, be proactive, address patient needs safely and effectively, and solicit feedback to improve quality of life.

Global Medical Device Podcast powered by greenlight.guru

Identifying the Positive and Negative Effects of COVID-19 on the Medical Device Industry

Citeline places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Citeline is a leader in the field of healthcare industry information.

Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up to date on the latest breakthroughs in medical technology with the top five news stories to get your day started. Subscribe and join us every weekday for your daily medtech news roundup.

The Global Medical Device Podcast, powered by Greenlight Guru, is where today's brightest minds in the medical device industry go to get their most useful and actionable insider knowledge, direct from some of the world's leading medical device experts and companies.

The DeviceTalks Podcast Network delivers news, insights and commentary from MedTech industry leaders, primarily from the largest OEMs in healthcare. Our podcasts will inspire MedTech professionals to create better MedTech devices and companies.

Explore the DeviceTalks Podcast Network, home to more than 11 podcasts:

• DeviceTalks Weekly
• AbbottTalks
• Boston Scientific Talks
• DeviceTalks AI
• IntuitiveTalks
• MedtechWOMEN Talks
• MedtronicTalks
• Neuro Innovation Talks: J&J MedTech Neuro
• Structural Heart Talks: Edwards Lifesciences
• Ortho Innovation Talks: Zimmer Biomet
• StrykerTalks

WATCH our video podcasts on www.youtube.com/@DeviceTalks

Connect with the hosts:
Tom Salemi, Editorial Director, DeviceTalks https://www.linkedin.com/in/tom-salemi-7118948/
Kayleen Brown, Managing Editor, DeviceTalks https://www.linkedin.com/in/kayleenbrown/

Learn more about DeviceTalks - Podcasts • Conferences • Webinars - www.devicetalks.com

Popular tracks tagged #medtech